At the time of this writing, the stock of United Parcel Service (NYSE: UPS) is down 17.5% since reporting fourth-quarter and full-year 2024 results on Jan. 30.
The dividend stock is now hovering around its lowest level in more than four years and is down over 50% from its all-time high.
Here’s why the sell-off in UPS is a buying opportunity despite serious challenges with the underlying business.
One look at the following chart and it’s easy to see why the stock has sold off.
The company enjoyed a period of sizable sales growth and margin expansion during the pandemic. However, it has failed to build upon that growth over the last few years, and margins have declined closer to pre-pandemic levels.
UPS’ forecasts for 2025 show few reasons to be optimistic. Management is guiding for $89 billion in revenue and 10.8% operating margins. The guidance essentially indicates a return to 2023 results, a year in which UPS had $90.96 billion in revenue and adjusted operating margins of 10.9%.
Given years of overpromising and underdelivering, it admittedly has become increasingly challenging to be optimistic about a UPS turnaround. But the good news is that the company seems to have a better handle on where it wants to go and isn’t afraid to communicate the anticipated pain that investors must endure in the meantime.
What stood out in the latest earnings call was an anticipated 50% reduction in delivery volumes from Amazon, UPS’ largest customer, by the second half of 2026. The shipping company is making the move to boost margins by focusing on its most profitable segments.
In October 2019, UPS launched its Digital Access Program (DAP) to grow its e-commerce business by offering small and medium-size businesses (SMBs) valuable tools and services.
DAP hit the ground running, becoming a $1.3 billion business in 2021. The company has since built upon that momentum, growing DAP revenue by 17% in 2024 to $3.3 billion.
Another standout in 2024 was growth in healthcare. Despite an overall volume decline in business-to-business (B2B) customers, UPS experienced growth in healthcare B2B, as well as healthcare with SMBs. On Jan. 8, it completed its acquisition of Frigo-Trans, a European healthcare logistics company specializing in cold-chain shipments. In December, UPS opened two healthcare cross-dock facilities for rapid transfers of temperature-sensitive products — one in Germany and the other in Italy.
Healthcare is an instrumental part of the company’s long-term growth plan. In its March 2024 investor presentation, management said it expected healthcare revenue to double by 2026 as it leaned into time- and temperature-sensitive shipments. In fact, the increase in healthcare was expected to be so large that it comprised roughly half of overall revenue growth projected for between 2023 and 2026.